Table 2.
Intervention group (ropivacaine) (n = 26) |
Placebo group (saline) (n = 27) |
|
---|---|---|
Sex (M/F) | 9/17 | 3/24 |
Age (y) | 35 (18–54) | 31 (18–55) |
Weight (kg) | 79 (50–127) | 70 (48–105) |
Height (cm) | 173 (162–193) | 171 (154–193) |
Surgeon 1/Surgeon 2 | 9/17 | 13/14 |
Duration of surgery (min) | 83 (65–110) | 77 (63–123) |